Related Experiment Video
Updated: Sep 16, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
ABCA4-associated disease in childhood and adolescence- a phenotype study
Jan-Philipp Bodenbender1, Annekatrin Rickmann2, Katarina Stingl3
1Centre for Ophthalmology, University Eye Hospital, University of Tübingen, Tübingen, Germany. jan-philipp.bodenbender@med.uni-tuebingen.de.
Insights
Current Stargardt disease research in children is limited. Our findings show that adult criteria, such as autofluorescence, are not suitable for pediatric studies, necessitating new approaches for this age group.
Area of Science:
- Ophthalmology
- Genetics
- Pediatric Research
Background:
- Observational studies on Stargardt disease primarily focus on adults.
- Existing adult-based findings and endpoints are used for pediatric interventional studies.
- Current clinical trials often rely on measuring definitely decreased autofluorescence.
Purpose of the Study:
- To investigate the variability of Stargardt disease specifically in pediatric populations.
- To evaluate the suitability of adult-derived inclusion criteria and endpoints for children.
- To identify appropriate methodologies for pediatric Stargardt disease research.
Main Methods:
- Close examination of Stargardt disease variability in children.
- Analysis of the prevalence of specific biomarkers in pediatric cohorts.
- Comparison of adult and pediatric Stargardt disease characteristics.
Main Results:
- Stargardt disease exhibits significant variability in children.
- The endpoint of definitely decreased autofluorescence has a very low prevalence in pediatric Stargardt disease cohorts.
- Current adult-based inclusion criteria and endpoints are not appropriate for children.
Conclusions:
- Pediatric Stargardt disease requires distinct inclusion criteria and endpoints.
- Definitely decreased autofluorescence is not a suitable endpoint for pediatric Stargardt disease studies.
- Future research must adapt methodologies for accurate assessment in children.
Key Messages:
WHAT IS KNOWN : So far, observational studies have primarily examined adults and have used these findings to define endpoints for interventional studies, which also serve as a reference for interventional studies in children Most clinical trials currently use the measurement of definitely decreased autofluorescence WHAT IS NEW : We have closely examined the variability of Stargardt disease in children Our results suggest that the same inclusion criteria and endpoints used for adults should not be applied to children, e.g. definitely decreased autofluorescence is not suitable in pediatric cohorts because it has only a very low prevalence.
More Related Videos
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Lingo
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pedigree Analysis
Pleiotropy